Medical Card
Get Your Medical Marijuana Card Today
Meet with a healthcare provider in minutes and receive the best care for the best value.
Explore A-Z conditions
Pancreatic Cancer
Cannabis for Pancreatic Cancer
Pancreatic cancer is a type of cancer that starts in the pancreas, which is an organ behind the stomach responsible for blood-glucose regulation, the production of insulin, and helps in digesting food. Pancreatic cancer is a fairly aggressive cancer with quite a low survival rate — 10% for all stages combined.
Due to this low survival rate, new treatments for pancreatic cancer are sorely needed. Interestingly, the most recent study on cannabis for pancreatic cancer didn’t involve cannabinoids, but the flavonoid FBL-03G, which is a version of cannflavin B. The flavonoid inhibits cancer cell proliferation and induced apoptosis. THC and CBD also have similar properties, inhibiting pancreatic cancer cell growth by targeting the PAK 1 protein and antagonizing the G protein-coupled receptor, GPR53.
Get your medical marijuana card
Connect with a licensed physician online in minutes.
Animal Study
8
Clinical Trial
1
Laboratory Study
10
Meta-analysis
13
Total studies
Pancreatic Cancer
32
Positive
28 studies
88%
Negative
3 studies
9%
Inconclusive
1 studies
3%
Do I qualify?
Select your state from the drop down and we’ll let you know.
Relevant studies
The information in our comprehensive A to Z encyclopedia comes from real scientific studies.
Uncover the detailed results of these studies and find out how effective medical marijuana is for dozens of conditions.
- A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic Cancer Cells
- Antitumor Effects of Cannabinoids in Human Pancreatic Ductal Adenocarcinoma Cell Line (Capan-2)-Derived Xenograft Mouse Model
- Antitumor effects of α-bisabolol against pancreatic cancer
- A Pilot Study of Perillyl Alcohol in Pancreatic Cancer
- Cannabinoid Derivatives Induce Cell Death In Pancreatic MIA PaCa-2 Cells Via A Receptor-independent Mechanism